Stay updated on Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial
Sign up to get notified when there's something new on the Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial page.

Latest updates to the Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial page
- Check6 days agoChange DetectedThe page now shows Revision: v3.3.2, replacing Revision: v3.3.1, which is a cosmetic metadata update and does not affect study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check13 days agoChange DetectedFooter revision label updated from v3.2.0 to v3.3.1, with no changes to study details, locations, or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedAn administrative banner regarding government funding and NIH operating status, previously shown on the study page, has been removed.SummaryDifference0.3%

- Check34 days agoChange DetectedNo significant additions or deletions were observed on the Study Details page; the page text and structure appear unchanged.SummaryDifference0.4%

- Check63 days agoChange DetectedAdded a prominent operating-status notice and a new v3.2.0 revision; removed the previous v3.1.0. This signals a status update and version upgrade.SummaryDifference2%

- Check70 days agoChange DetectedStandardizes a medical condition name to proper case and updates the revision version from v3.0.2 to v3.1.0.SummaryDifference0.1%

Stay in the know with updates to Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial page.